Ergomed Awards Share Options

RNS Number : 1076K

Ergomed plc

24 December 2015

 

Ergomed Awards Share Options

Guildford, UK - 24 December 2015: Ergomed plc, (LSE: ERGO or 'Ergomed') a profitable UK-based company, dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, announces that the following awards have been made under its unapproved executive share option scheme to certain directors of the Company.

The awards consist of share options over the Company's ordinary shares of 1p each (the "Options"), with an exercise price of 169 pence (being the closing price on 23 December 2015) which will vest on  3 June 2018 but are not subject to any performance criteria. Once vested, the Options will be exercisable until 23 December 2025.

Director	Award of Options	Resulting interest in options	Current shareholding in the Company
Neil Clark - Chief Financial Officer	150,000	1,150,000	91,912
Andrew Mackie - Chief Business Officer	125,000	125,000	NIL

In total 275,000 Options were granted yesterday, representing 0.96% of the issued share capital.  

For further information, please contact:

Hume Brophy - for UK enquiries

Mary Clark, Supriya Mathur and Hollie Vile

Tel: + 44 203 440 5654

[e-mail]

Stifel

NOMAD/Broker to the Company

Jonathan Senior, Stewart Wallace and Ben Maddison

Tel: [phone]

MC Services - for Continental European enquiries

Anne Hennecke

Tel: [phone]

[e-mail]

 

END

 

 

RDSEANADAEFSFFF